Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital Tuebingen

About this trial

This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

existing indication for radiation therapy

minimum age 18 years, no upper age limit

capacity for consent

Informed consent

Disqualifiers

contraindication for MRI (claustrophobia, metallic implants not applicable for MRI

pregnancy

Trial design

Design model

Single group

Treatments tested in this trial

  • Radiotherapy on the MR-Linac

    Radiation

    Radiotherapy is performed on the 1.5 T MR Linac

  • Imaging on the MR Linac

    Diagnostic test

    Only imaging performed on the MR Linac

Treatment groups

472 Participants
are divided into 9 treatment groups

9

Treatment groups

See each treatment group below.

Group A: Rectal and anal cancerExperimental treatment 1 intervention
Group B: Prostate cancerExperimental treatment 1 intervention
Group C: Head and neck cancerExperimental treatment 1 intervention
Group D: Esophageal cancerExperimental treatment 1 intervention
Group E: Breast CancerExperimental treatment 1 intervention
Group F: Central nervous system tutorsExperimental treatment 1 intervention
Group G: Palliative treatmentsExperimental treatment 1 intervention
Group H: OtherExperimental treatment 1 intervention
Group I: Imaging onlyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility of online MR guided Radiotherapy

Treatment of a patient is considered feasible when 85% of treatments were completed as planned in this patient

Time frame
During every single patients treatment (i.e. between one to seven weeks after the first application of radiotherapy)

Secondary outcomes

1

Time analysis

Time required for online MR guided radiotherapy

Time frame
During every single patients treatment (i.e. between one to seven weeks after the first application of radiotherapy)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.